A Prospective Study
Authors:
- Jean-Pierre VilleneuveJVJean-Pierre Villeneuve
- Gilles Pomier-LayrarguesGPGilles Pomier-Layrargues
- Lester DuguayLDLester Duguay
- Real LapointeRLReal Lapointe
- Serge TanguaySTSerge Tanguay
- Denis MarleauDMDenis Marleau
- Bernard WillemsBWBernard Willems
- P. -Michel HuetPHP. -Michel Huet
- Claire Infante-RivardCIClaire Infante-Rivard
- Pierre LavoiePLPierre Lavoie
- 1 July 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 206 (1) , 48-52
Abstract
Emergency portocaval shunt for variceal bleeding is associated with a high operative mortality, particularly if used as a last resort. Because of this, a strong case has been made against emergency shunt. This report describes an experience with emergency portacaval shunt for the treatment of variceal bleeding when used systematically ater hemodynamic stabilization and control of the bleeding episode with balloon tamponade, if necessary, in patients with mild or moderate liver disease. The population studied comprised 62 consecutive patients who rebled from varices while participating in a controlled trial of propranolol for the prevention of rebleeding. Of the 62 patients, nine died of massive hemorrhage and 53 survived the hemorrhage. Of the 53 survivors, 11 had severe liver disease and were not considered for shunt surgery. Of the remaining 42 patients with mild or moderate liver disease, 36 had emergency central portocaval shunt. The interval between endoscopic diagnosis of variceal bleeding and surgery averaged 19 .+-. 3 hours (mean .+-. SE). The operative mortality rate, defined as in-hospital mortality, was 19%. One- and 2-year survival rates were 78% and 71%, respectively. The incidence of postoperative hepatic encephalopathy was 36%; all patients responded favorably to protein restriction and lactulose. Thus, under specific conditions, emergency portocaval shunt results in an acceptable long-term survival rate. In patients with mild or moderate liver disease, emergency portocaval shunt should be considered when other forms of treatment for the prevention of variceal rebleeding have failed.Keywords
This publication has 18 references indexed in Scilit:
- Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trialHepatology, 1986
- Endoscopic Sclerotherapy versus Portacaval Shunt in Patients with Severe Cirrhosis and Variceal HemorrhageNew England Journal of Medicine, 1984
- FAILURE OF REPEATED INJECTION SCLEROTHERAPY TO IMPROVE LONG-TERM SURVIVAL AFTER OESOPHAGEAL VARICEAL BLEEDINGThe Lancet, 1983
- Variceal hemorrhage: a critical evaluation of survival analysis.1982
- Tamponade and injection sclerotherapy in the management of bleeding oesophageal varicesBritish Journal of Surgery, 1982
- The course of patients after variceal hemorrhageGastroenterology, 1981
- Analysis of operative mortality after portal decompressive procedures in cirrhotic patientsThe American Journal of Surgery, 1980
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Life-threatening hemorrhage of the digestive tract in cirrhotic patientsThe American Journal of Surgery, 1976
- Treatment of Hepatic Coma by Exchange Blood TransfusionNew England Journal of Medicine, 1966